You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AZULFIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Azulfidine patents expire, and when can generic versions of Azulfidine launch?

Azulfidine is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Azulfidine

A generic version of AZULFIDINE was approved as sulfasalazine by WATSON LABS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZULFIDINE?
  • What are the global sales for AZULFIDINE?
  • What is Average Wholesale Price for AZULFIDINE?
Summary for AZULFIDINE
Drug patent expirations by year for AZULFIDINE
Drug Prices for AZULFIDINE

See drug prices for AZULFIDINE

Recent Clinical Trials for AZULFIDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Erlangen-Nürnberg Medical SchoolPhase 3
Brigham and Women's HospitalPhase 4
Columbia UniversityPhase 4

See all AZULFIDINE clinical trials

Pharmacology for AZULFIDINE
Drug ClassAminosalicylate

US Patents and Regulatory Information for AZULFIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn AZULFIDINE sulfasalazine SUSPENSION;ORAL 018605-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer AZULFIDINE sulfasalazine TABLET;ORAL 007073-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073-002 Apr 6, 1983 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.